CME Group Inc. (NASDAQ: CME) reported revenue of $1.2 billion for the fourth quarter of 2022, up 5% year-over-year. Net income attributable to shareholders was $630 million, or $1.75 per share, compared to $613.3 million, or $1.71 per share, last year. Adjusted EPS was $1.92. Average daily volume (ADV) was 21.8 million contracts, up 6% versus last […]
CME Group Inc. (NASDAQ: CME) reported revenue of $1.2 billion for the fourth quarter of 2022, up 5% year-over-year. Net income attributable to shareholders was $630 million, or $1.75 per share, compared to $613.3 million, or $1.71 per share, last year. Adjusted EPS was $1.92. Average daily volume (ADV) was 21.8 million contracts, up 6% versus last […]
CME Group Inc. (NASDAQ: CME) reported revenue of $1.2 billion for the fourth quarter of 2022, up 5% year-over-year.
Net income attributable to shareholders was $630 million, or $1.75 per share, compared to $613.3 million, or $1.71 per share, last year. Adjusted EPS was $1.92.
Average daily volume (ADV) was 21.8 million contracts, up 6% versus last year.
